Privacy Policy: Research Review will record your email details on a secure database and will not release them to anyone without your prior approval. Research Review and you have the right to inspect, update or delete your details at any time. The views expressed in this Publication are personal to the authors, and do not necessarily represent the views or policy of the Ministry of Health on the issues dealt with in the publication.
Disclaimer: This publication is not intended as a replacement for regular medical education but to assist in the process. The reviews are a summarised interpretation of the published study and reflect the opinion of the writer rather than those of the research group or scientific journal. It is suggested readers review the full trial data before forming a final conclusion on its merits.
Research Review publications are intended for New Zealand health professionals.
Assessing the gaps in cardiovascular disease risk assessment and management in primary care for Māori and Pacific peoples in Aotearoa New Zealand
Authors: Wheeler A et al.
Summary: There are extensive and inequitable gaps in cardiovascular disease risk assessment and management for Māori and Pacific peoples in New Zealand, according to a systematic review of 69 studies published between 1 January 2000 and 31 December 2024. Māori and Pacific peoples had reduced adherence to primary prevention medications (antihypertensives and lipid-lowering therapy), were less likely to receive antiplatelets and lipid-lowering therapy for secondary prevention, and had reduced access to revascularisation compared with other ethnic groups. Opportunities to improve cardiovascular disease risk assessment and management included provision of adequate health literacy, involvement of whānau, patient-provider relationships, access to care, and enhanced cultural safety. While 64% of studies included in the review were of high quality as assessed using Mixed Methods Appraisal, 71% were of low quality as assessed using the Consolidated Criteria for Strengthening the Reporting of Health Research involving Indigenous Peoples (CONSIDER), in particular quantitative research and research including but not focusing on Māori and Pacific peoples.
Reference: Lancet Reg Health West Pac. 2025;56:101511.
Abstract
Respiratory research with Māori and Pacific children living in Aotearoa, New Zealand
Authors: Matenga-Ikihele A et al.
Summary: A systematic review and narrative synthesis found a lack of research on the lived experiences of Māori and Pacific children with respiratory conditions, and their whānau. A total of 29 studies published between 2010 and 2022, enrolling Māori or Pacific children aged 0–14 years, were included in the analysis. Most were retrospective cohort studies focused on asthma, group A streptococcus and lower respiratory tract infections. Only two studies reported using a Kaupapa Māori framework. Further research incorporating culturally responsive approaches is urgently needed to improve understanding of Māori and Pacific child respiratory health and to advance health equity, concluded the study authors.
Reference: J Prim Health Care. 2025;17(1):63-82.
Abstract